215 related articles for article (PubMed ID: 24810980)
21. [Anti-mullerian hormone in young women after chemotherapy and infradiaphragmatic radiotherapy for childhood cancer].
Krawczuk-Rybak M; Leszczyńska E; Wysocka J; Zelazowska-Rutkowska B
Pediatr Endocrinol Diabetes Metab; 2008; 14(2):99-103. PubMed ID: 18721496
[TBL] [Abstract][Full Text] [Related]
22. Long-Term Effects of Radioiodine Treatment on Female Fertility in Survivors of Childhood Differentiated Thyroid Carcinoma.
Nies M; Cantineau AEP; Arts EGJM; van den Berg MH; van Leeuwen FE; Muller Kobold AC; Klein Hesselink MS; Burgerhof JGM; Brouwers AH; van Dam EWCM; Havekes B; van den Heuvel-Eibrink MM; Corssmit EPM; Kremer LCM; Netea-Maier RT; van der Pal HJH; Peeters RP; Plukker JTM; Ronckers CM; van Santen HM; van der Horst-Schrivers ANA; Tissing WJE; Bocca G; van Dulmen-den Broeder E; Links TP
Thyroid; 2020 Aug; 30(8):1169-1176. PubMed ID: 32079487
[No Abstract] [Full Text] [Related]
23. Long-term antimüllerian hormone patterns differ by cancer treatment exposures in young breast cancer survivors.
Zhou B; Kwan B; Desai MJ; Nalawade V; Ruddy KJ; Nathan PC; Henk HJ; Murphy JD; Whitcomb BW; Su HI
Fertil Steril; 2022 May; 117(5):1047-1056. PubMed ID: 35216831
[TBL] [Abstract][Full Text] [Related]
24. Ovarian function after chemotherapy in young breast cancer survivors.
Morarji K; McArdle O; Hui K; Gingras-Hill G; Ahmed S; Greenblatt EM; Warner E; Sridhar S; Ali AMF; Azad A; Hodgson DC
Curr Oncol; 2017 Dec; 24(6):e494-e502. PubMed ID: 29270058
[TBL] [Abstract][Full Text] [Related]
25. Antral follicle count (AFC) and serum anti-Müllerian hormone (AMH) are the predictors of natural fecundability have similar trends irrespective of fertility status and menstrual characteristics among fertile and infertile women below the age of 40 years.
Khan HL; Bhatti S; Suhail S; Gul R; Awais A; Hamayun H; Enver F; Abbas S; Hassan Z; Nisar R; Sardar S; Asif W
Reprod Biol Endocrinol; 2019 Feb; 17(1):20. PubMed ID: 30744650
[TBL] [Abstract][Full Text] [Related]
26. The use of anti-Müllerian hormone for controlled ovarian stimulation in assisted reproductive technology, fertility assessment and -counseling.
Pilsgaard F; Grynnerup AG; Løssl K; Bungum L; Pinborg A
Acta Obstet Gynecol Scand; 2018 Sep; 97(9):1105-1113. PubMed ID: 29476703
[TBL] [Abstract][Full Text] [Related]
27. Female adolescents and young women previously treated for pediatric malignancies: assessment of ovarian reserve and gonadotoxicity risk stratification for early identification of patients at increased infertility risk.
Parissone F; Di Paola R; Balter R; Garzon S; Zaffagnini S; Neri M; Vitale V; Tridello G; Cesaro S
J Pediatr Endocrinol Metab; 2021 Jan; 34(1):25-33. PubMed ID: 33068384
[TBL] [Abstract][Full Text] [Related]
28. Self-collected dried blood spots as a tool for measuring ovarian reserve in young female cancer survivors.
Roberts SC; Seav SM; McDade TW; Dominick SA; Gorman JR; Whitcomb BW; Su HI
Hum Reprod; 2016 Jul; 31(7):1570-8. PubMed ID: 27170433
[TBL] [Abstract][Full Text] [Related]
29. Genetic variation may modify ovarian reserve in female childhood cancer survivors.
van Dorp W; van den Heuvel-Eibrink MM; Stolk L; Pieters R; Uitterlinden AG; Visser JA; Laven JS
Hum Reprod; 2013 Apr; 28(4):1069-76. PubMed ID: 23360674
[TBL] [Abstract][Full Text] [Related]
30. Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception.
Bentzen JG; Forman JL; Pinborg A; Lidegaard Ø; Larsen EC; Friis-Hansen L; Johannsen TH; Nyboe Andersen A
Reprod Biomed Online; 2012 Dec; 25(6):612-9. PubMed ID: 23069740
[TBL] [Abstract][Full Text] [Related]
31. Influence of adjuvant chemotherapy on anti-Müllerian hormone in women below 35 years treated for early breast cancer.
Perdrix A; Saint-Ghislain M; Degremont M; David M; Khaznadar Z; Loeb A; Leheurteur M; Di Fiore F; Clatot F
Reprod Biomed Online; 2017 Oct; 35(4):468-474. PubMed ID: 28652099
[TBL] [Abstract][Full Text] [Related]
32. Use of anti-Müllerian hormone testing during ovarian reserve screening to identify women at risk of polycystic ovary syndrome.
Safier LZ; Grossman LC; Chan CW; Sauer MV; Lobo RA; Douglas NC
Int J Gynaecol Obstet; 2016 Oct; 135(1):73-6. PubMed ID: 27350232
[TBL] [Abstract][Full Text] [Related]
33. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
[TBL] [Abstract][Full Text] [Related]
34. Protective effect of goserelin on ovarian reserve during (neo)adjuvant chemotherapy in young breast cancer patients: a prospective cohort study in China.
Wang S; Pei L; Hu T; Jia M; Wang S
Hum Reprod; 2021 Mar; 36(4):976-986. PubMed ID: 33411897
[TBL] [Abstract][Full Text] [Related]
35. Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations.
Phillips KA; Collins IM; Milne RL; McLachlan SA; Friedlander M; Hickey M; Stern C; Hopper JL; Fisher R; Kannemeyer G; Picken S; Smith CD; Kelsey TW; Anderson RA;
Hum Reprod; 2016 May; 31(5):1126-32. PubMed ID: 27094481
[TBL] [Abstract][Full Text] [Related]
36. Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Müllerian hormone, inhibin B and ovarian ultrasound.
Bath LE; Wallace WH; Shaw MP; Fitzpatrick C; Anderson RA
Hum Reprod; 2003 Nov; 18(11):2368-74. PubMed ID: 14585889
[TBL] [Abstract][Full Text] [Related]
37. Serum anti-Müllerian hormone concentration and follicle density throughout reproductive life and in different diseases-implications in fertility preservation.
Liebenthron J; Reinsberg J; van der Ven K; Saenger N; Kruessel JS; von Wolff M
Hum Reprod; 2019 Dec; 34(12):2513-2522. PubMed ID: 31782794
[TBL] [Abstract][Full Text] [Related]
38. Low serum concentrations of anti-Müllerian hormone are common in 53 female childhood cancer survivors.
Miyoshi Y; Ohta H; Namba N; Tachibana M; Miyamura T; Miyashita E; Hashii Y; Oue T; Isobe A; Tsutsui T; Kimura T; Ozono K
Horm Res Paediatr; 2013; 79(1):17-21. PubMed ID: 23295306
[TBL] [Abstract][Full Text] [Related]
39. [Anti-Müllerian hormone as a new marker of the ovarian reserve function preservation by goserelin during (neo)adjuvant chemotherapy for young breast cancer patients].
Wang SY; Wang S
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Jun; 51(3):536-541. PubMed ID: 31209428
[TBL] [Abstract][Full Text] [Related]
40. Utility of Ovarian Reserve Screening with Anti-Müllerian Hormone for Reproductive Age Women Deferring Pregnancy.
Grossman LC; Safier LZ; Kline MD; Chan CW; Lobo RA; Sauer MV; Douglas NC
J Womens Health (Larchmt); 2017 Apr; 26(4):345-351. PubMed ID: 27906603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
